SCHEMBL4694870

SCHEMBL4694870

COCCn1nc(-c2ccc(C(C)(C)C)cc2)cc1C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 6/20 0.59
▸ PPARA Q07869 6/20 0.59
▸ PPARD Q03181 5/20 0.59
▸ NR1H4 Q96RI1 3/20 0.44
▸ GRN P28799 1/20 0.43
▸ SORT1 Q99523 1/20 0.43
▸ PHGDH O43175 1/20 0.42
▸ MAPT P10636 3/20 0.41
▸ XBP1 P17861 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4692575 0.86 PPARG (0.56) PPARGPPARAPPARDMAPTLMNA
SCHEMBL596086 0.86 L3MBTL1 (0.51) PPARGPPARAPPARDGRNSORT1
SCHEMBL4692309 0.83 PPARG (0.54) PPARGPPARAPPARDNR1H4GRN
SCHEMBL4689445 0.82 GRN (0.66) PPARGPPARAPPARDNR1H4GRN
SCHEMBL4692297 0.79 PPARG (0.57) PPARGPPARAPPARDNR1H4GRN
SCHEMBL4689814 0.79 GRN (0.64) GRNSORT1MAPTNPSR1MEN1
SCHEMBL4688310 0.79 KDM4E (0.55) PPARGPPARAPPARDNR1H4GRN
SCHEMBL4690961 0.78 PPARG (0.60) PPARGPPARAPPARDNR1H4CNR1
SCHEMBL2333453 0.77 POLB (0.53) PPARGPPARAPPARDNR1H4GRN
SCHEMBL28767211 0.77 GRN (0.61) GRNSORT1MAPTXBP1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1685113-B1 SUBSTITUTED PYRAZOLES AS PPAR AGONISTS SMITHKLINE BEECHAM CORP (US) 2008-07-30 — — EP disclosed
EP-1685113-B1 SUBSTITUTED PYRAZOLES AS PPAR AGONISTS SMITHKLINE BEECHAM CORP (US) 2008-07-30 — — EP disclosed
US-20080021030-A1 Substituted Pyrazoles As Ppar Agonists SMITHKLINE BEECHAM CORPORATION 2008-01-24 — — US disclosed
US-20080021030-A1 Substituted Pyrazoles As Ppar Agonists SMITHKLINE BEECHAM CORPORATION 2008-01-24 — — US disclosed
US-20080021030-A1 Substituted Pyrazoles As Ppar Agonists SMITHKLINE BEECHAM CORPORATION 2008-01-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021030-A1 Substituted Pyrazoles As Ppar Agonists PPARD, PPARA, PPARG PPARG 3/4885PPARA 2/4885PPARD 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback